Study supports TAVR for lower-risk patients

04/7/2013 | TCTMD.com

Transcatheter aortic valve replacement may be an appropriate treatment for severe aortic stenosis in patients who are at low or intermediate risk for surgery, according to a study published in the European Heart Journal. "Compared with patients at calculated risk, well-selected patients with STS-defined intermediate or low risk appear to have favorable clinical outcomes," the authors of the Swiss study wrote. U.S.-based physicians are hopeful TAVR indications can be broadened if data continue to support doing so, said Dr. William Suh of the University of California, Los Angeles.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX